Cite
Correction: HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists.
MLA
Strutzenberg, Timothy S., et al. “Correction: HDX-MS Reveals Structural Determinants for RORγ Hyperactivation by Synthetic Agonists.” ELife, vol. 8, Oct. 2019. EBSCOhost, https://doi.org/10.7554/eLife.52847.
APA
Strutzenberg, T. S., Garcia-Ordonez, R. D., Novick, S. J., Park, H., Chang, M. R., Doebellin, C., He, Y., Patouret, R., Kamenecka, T. M., & Griffin, P. R. (2019). Correction: HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists. ELife, 8. https://doi.org/10.7554/eLife.52847
Chicago
Strutzenberg, Timothy S, Ruben D Garcia-Ordonez, Scott J Novick, HaJeung Park, Mi Ra Chang, Christelle Doebellin, Yuanjun He, Rémi Patouret, Theodore M Kamenecka, and Patrick R Griffin. 2019. “Correction: HDX-MS Reveals Structural Determinants for RORγ Hyperactivation by Synthetic Agonists.” ELife 8 (October). doi:10.7554/eLife.52847.